Seattle Genetics, Inc. : SGEN

All SGEN Articles

84 Articles

Jon C. Ogg | Mar 10, 2014 at 8:25 AM EDT

Cantor Fitzgerald Says Sell Twitter and Five Other Stocks Now

After a very long run in the market from the 2009 lows, there is always the chance a healthy correction…

Trey Thoelcke | Feb 15, 2014 at 9:05 AM EST

The Top Five Analyst Sell Ratings This Week

In a week that saw the markets continue to march higher, some of the top Wall Street firms that we…

Jon C. Ogg | Feb 14, 2014 at 8:20 AM EST

Wall Street Analysts Issue More Sell Ratings on Big Stocks

courtesy Deere & Co.Despite the fact that the market has enjoyed a nice bounce from the January sell-off, we are…

Lee Jackson | Sep 4, 2013 at 8:25 AM EDT

UBS Picks Large Cap Biotechnology Stocks to Outperform the Rest of 2013

ThinkstockEven though the equity strategy team at UBS has downgraded U.S. equities to Neutral from Outperform, they remain very positive…

Jon C. Ogg | Jul 2, 2013 at 8:45 AM EDT

Which Biotech Stocks Are Buyout Targets After Onyx Pharmaceutical Rejects Amgen?

ThinkstockOn Friday after the market closed, biotech giant Amgen Inc. (NASDAQ: AMGN) made an unsolicited $120 per share bid for…

Jon C. Ogg | Jun 4, 2013 at 7:50 AM EDT

Top 12 Analyst Upgrades and Downgrades: FedEx, GE, Ulta Salon and Walmart

These are the top analyst upgrades, downgrades and initiations from select Wall Street research calls on Tuesday, June 4, 2013.…

Jon C. Ogg | Nov 13, 2012 at 8:15 AM EST

Top Analyst Upgrades and Downgrades (APD, BERY, CL, CXS, DOW, FFIV, FMS, IMGN, LF, MCP, NS, OMC, PDLI, REGN, SGEN, WU, WY, XOMA)

These are some of the top analyst upgrades, downgrades and initiations seen in Wall St. research calls this Monday. Air…

Jon C. Ogg | Nov 8, 2012 at 8:46 AM EST

Thursday’s Big Stocks on the Move (CNQR, DUSA, GHDX, GNC, LOCK, MNST, PTN, QCOM, SGEN, TNK, WFM)

We have many stocks moving this morning. 24/7 Wall St. has tracked moves in shares of the following: Concur Technologies…

Jon C. Ogg | Sep 7, 2012 at 7:55 AM EDT

Top Analyst Upgrades and Downgrades (AAP, APOL, ADNC, BCS, BGFV, GME, GMCR, NVDA, PCLN, RKT, SGEN, SON, STI, URBN, WY, FINL, DSW, FL, CNK, NCMI, RGC)

Jon OggThese are some of the top analyst upgrades, downgrades and initiations seen from Wall St. research calls this Friday.…

Jon C. Ogg | May 18, 2012 at 7:47 AM EDT

An Early Look at 2012 ASCO Biotech Cancer Stocks (DNDN, LLY, AMGN, ARIA, ARQL, ARRY, AVEO, BVTI, ABPI, BMY, CLDX, CYTR, CYCC, GALE, EXEL, GNBT, GHDX, IMGN, MYGN, NKTR, NLNK, ONXX, OPTR, PCYC, SGEN, SNSS, SNTA)

We are now just about two weeks away from the king of biotech and pharma events in cancer treatments. The 2012…

Jon C. Ogg | May 10, 2012 at 12:02 PM EDT

Taking An Early Look at 2012 ASCO Biotech/Cancer Stocks (DNDN, LLY, ARIA, ARRY, BVTI, ABPI, CLDX, CYTR, GALE, EXEL, GNBT, GHDX, IMGN, NKTR, NLNK, PCYC, SGEN)

It is now getting close to the middle of May, and that means one thing for biotech investors. The king…

Paul Ausick | Nov 4, 2011 at 4:09 PM EDT

24/7 Wall St. Closing Bell (GRPN, BIG, DAL, RGLD, SD, SPWRA, TSL, SBUX, LNKD, ANLY, OXGN, RST, MTZ, ALJ, DRWI, LEDS, CHK, IPSU, SGEN)

Markets opened lower this morning, and a modest gain of 80,000 non-farm jobs and a slight improvement of the US…

Jon C. Ogg | Aug 27, 2011 at 7:31 AM EDT

24/7 Wall St. Top Analyst Calls of the Week (AAPL, BAC, BSX, GOOG, HGSI, JNPR, NDAQ, NEM, P, PCLN, RIMM, SGEN, SQNM, SLM, VVUS, VMW, INT, JPM, GOOG)

Jon OggEach morning we review our top upgrades, downgrades, and initiations from Wall Street analysts. At the end of the…

Jon C. Ogg | Aug 22, 2011 at 1:17 PM EDT

Why “Sell the News” on Seattle Genetics (SGEN)

There is an old rule of thumb from biotech investors and traders… SELL FDA APPROVALS. This is very counter-intuitive on…

Jon C. Ogg | Aug 22, 2011 at 8:29 AM EDT

Top Analyst Upgrades & Downgrades (AGU, IPI, NEM, OVTI, PMI, SGEN, SLM, SPWRA, TM, UA, YGE)

Jon OggThese are some of the top analyst upgrades, downgrades, and initiations seen from Wall Street research calls this Monday…

1 … 3 4 5 6

Seattle Genetics, Inc. : SGEN

All SGEN Articles

Cantor Fitzgerald Says Sell Twitter and Five Other Stocks Now

The Top Five Analyst Sell Ratings This Week

Wall Street Analysts Issue More Sell Ratings on Big Stocks

UBS Picks Large Cap Biotechnology Stocks to Outperform the Rest of 2013

Which Biotech Stocks Are Buyout Targets After Onyx Pharmaceutical Rejects Amgen?

Top 12 Analyst Upgrades and Downgrades: FedEx, GE, Ulta Salon and Walmart

Top Analyst Upgrades and Downgrades (APD, BERY, CL, CXS, DOW, FFIV, FMS, IMGN, LF, MCP, NS, OMC, PDLI, REGN, SGEN, WU, WY, XOMA)

Thursday’s Big Stocks on the Move (CNQR, DUSA, GHDX, GNC, LOCK, MNST, PTN, QCOM, SGEN, TNK, WFM)

Top Analyst Upgrades and Downgrades (AAP, APOL, ADNC, BCS, BGFV, GME, GMCR, NVDA, PCLN, RKT, SGEN, SON, STI, URBN, WY, FINL, DSW, FL, CNK, NCMI, RGC)

An Early Look at 2012 ASCO Biotech Cancer Stocks (DNDN, LLY, AMGN, ARIA, ARQL, ARRY, AVEO, BVTI, ABPI, BMY, CLDX, CYTR, CYCC, GALE, EXEL, GNBT, GHDX, IMGN, MYGN, NKTR, NLNK, ONXX, OPTR, PCYC, SGEN, SNSS, SNTA)

Taking An Early Look at 2012 ASCO Biotech/Cancer Stocks (DNDN, LLY, ARIA, ARRY, BVTI, ABPI, CLDX, CYTR, GALE, EXEL, GNBT, GHDX, IMGN, NKTR, NLNK, PCYC, SGEN)

24/7 Wall St. Closing Bell (GRPN, BIG, DAL, RGLD, SD, SPWRA, TSL, SBUX, LNKD, ANLY, OXGN, RST, MTZ, ALJ, DRWI, LEDS, CHK, IPSU, SGEN)

24/7 Wall St. Top Analyst Calls of the Week (AAPL, BAC, BSX, GOOG, HGSI, JNPR, NDAQ, NEM, P, PCLN, RIMM, SGEN, SQNM, SLM, VVUS, VMW, INT, JPM, GOOG)

Why “Sell the News” on Seattle Genetics (SGEN)

Top Analyst Upgrades & Downgrades (AGU, IPI, NEM, OVTI, PMI, SGEN, SLM, SPWRA, TM, UA, YGE)

A 70-Year-Old With $1.4 Million Faces a $62,000 RMD That Pushes Him Into a Higher Tax Bracket

A Couple’s $1.2 Million Portfolio Faces a 3.9% Withdrawal Rate That Feels Safe but Is Not

NVIDIA’s New Quantum‑AI Models Are Impressive — and the Market Doesn’t Seem Ready to Price the Step‑Change

A 70-Year-Old With $1.4 Million Faces a $62,000 RMD That Pushes Him Into a Higher Tax Bracket

A Couple's $1.2 Million Portfolio Faces a 3.9% Withdrawal Rate That Feels Safe but Is Not

A 70-Year-Old With $1.4 Million Faces a $62,000 RMD That Pushes Him Into a Higher Tax Bracket

A Couple’s $1.2 Million Portfolio Faces a 3.9% Withdrawal Rate That Feels Safe but Is Not

Seattle Genetics, Inc. : SGEN

All SGEN Articles

Cantor Fitzgerald Says Sell Twitter and Five Other Stocks Now

The Top Five Analyst Sell Ratings This Week

Wall Street Analysts Issue More Sell Ratings on Big Stocks

UBS Picks Large Cap Biotechnology Stocks to Outperform the Rest of 2013

Which Biotech Stocks Are Buyout Targets After Onyx Pharmaceutical Rejects Amgen?

Top 12 Analyst Upgrades and Downgrades: FedEx, GE, Ulta Salon and Walmart

Top Analyst Upgrades and Downgrades (APD, BERY, CL, CXS, DOW, FFIV, FMS, IMGN, LF, MCP, NS, OMC, PDLI, REGN, SGEN, WU, WY, XOMA)

Thursday’s Big Stocks on the Move (CNQR, DUSA, GHDX, GNC, LOCK, MNST, PTN, QCOM, SGEN, TNK, WFM)

Top Analyst Upgrades and Downgrades (AAP, APOL, ADNC, BCS, BGFV, GME, GMCR, NVDA, PCLN, RKT, SGEN, SON, STI, URBN, WY, FINL, DSW, FL, CNK, NCMI, RGC)

An Early Look at 2012 ASCO Biotech Cancer Stocks (DNDN, LLY, AMGN, ARIA, ARQL, ARRY, AVEO, BVTI, ABPI, BMY, CLDX, CYTR, CYCC, GALE, EXEL, GNBT, GHDX, IMGN, MYGN, NKTR, NLNK, ONXX, OPTR, PCYC, SGEN, SNSS, SNTA)

Taking An Early Look at 2012 ASCO Biotech/Cancer Stocks (DNDN, LLY, ARIA, ARRY, BVTI, ABPI, CLDX, CYTR, GALE, EXEL, GNBT, GHDX, IMGN, NKTR, NLNK, PCYC, SGEN)

24/7 Wall St. Closing Bell (GRPN, BIG, DAL, RGLD, SD, SPWRA, TSL, SBUX, LNKD, ANLY, OXGN, RST, MTZ, ALJ, DRWI, LEDS, CHK, IPSU, SGEN)

24/7 Wall St. Top Analyst Calls of the Week (AAPL, BAC, BSX, GOOG, HGSI, JNPR, NDAQ, NEM, P, PCLN, RIMM, SGEN, SQNM, SLM, VVUS, VMW, INT, JPM, GOOG)

Why “Sell the News” on Seattle Genetics (SGEN)

Top Analyst Upgrades & Downgrades (AGU, IPI, NEM, OVTI, PMI, SGEN, SLM, SPWRA, TM, UA, YGE)

A 70-Year-Old With $1.4 Million Faces a $62,000 RMD That Pushes Him Into a Higher Tax Bracket

A Couple’s $1.2 Million Portfolio Faces a 3.9% Withdrawal Rate That Feels Safe but Is Not

NVIDIA’s New Quantum‑AI Models Are Impressive — and the Market Doesn’t Seem Ready to Price the Step‑Change

Featured Reads

A 70-Year-Old With $1.4 Million Faces a $62,000 RMD That Pushes Him Into a Higher Tax Bracket

A Couple's $1.2 Million Portfolio Faces a 3.9% Withdrawal Rate That Feels Safe but Is Not